【2h】

Comparison of endoscopic ultrasound-guided fine-needle aspiration and biopsy with 22-gauge and 25-gauge needles for the precision medicine of pancreatic cancer

机译:内镜超声引导下细针穿刺活检与22针和25针针用于胰腺癌精密药物的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We compared the sample volume of endoscopic ultrasound-guided fine-needle aspiration and biopsy (EUS-FNAB) specimens obtained by 22-gauge (22G) and 25-gauge (25G) needles, and the accuracy rate.This was a retrospective study in a single tertiary referral center. We investigated 153 patients with pancreatic ductal adenocarcinoma (PDAC) who underwent diagnostic EUS-FNAB before neoadjuvant gemcitabine-based chemoradiotherapy between October 2006 and November 2015. We performed immunohistochemical (IHC) analysis of human equilibrative nucleoside transporter 1 using the remnant cell blocks following pathological PDAC diagnosis. We compared the sampling rate, accuracy rate, and success rate of IHC analysis between 22G and 25G.There were 70 patients in the 22G group and 83 patients in the 25G group. The overall sampling rates on cytology and histology were 100% and 98.0%, respectively. The sampling rate did not differ between the 22G and 25G groups. The overall diagnostic accuracy rates on cytology and histology were 94.8% and 79.7%, respectively. The accuracy rates of 22G and 25G groups on cytology were 94.3% and 95.2%, respectively, whereas those on histology were 80.0% and 79.5%, respectively. The diagnostic accuracy on cytology and histology did not differ significantly between the 22G and 25G groups. Of 153 histology specimens, 69.3% of those with PDAC provided sufficient samples for IHC analysis. The success rate of IHC analysis did not differ significantly between the 22G (67.1%) and 25G (71.1%) groups (P = .60).Both 22G and 25G provided a high diagnostic yield with equivalent accuracy rates on histology. EUS-FNAB specimens obtained using 22G or 25G can be equally adequate for IHC analysis and may be suitable for diagnostic examination. Further investigations such as EUS-FNAB needle design and novel cell block preparation are needed to obtain adequate samples for use in “precision medicine.”
机译:我们比较了22针(22G)和25针(25G)针获得的内镜超声引导下细针穿刺活检(EUS-FNAB)标本的样本量以及准确率,这是一项回顾性研究。单一的三级推荐中心。我们调查了2006年10月至2015年11月之间基于新辅助吉西他滨的放化疗前接受诊断性EUS-FNAB的胰腺导管腺癌(PDAC)的153例患者。在病理之后,我们使用残留的细胞阻滞剂对人体平衡核苷转运蛋白1进行了免疫组化(IHC)分析。 PDAC诊断。我们比较了22G和25G之间的IHC分析的采样率,准确率和成功率.22G组中有70例患者,而25G组中有83例患者。细胞学和组织学的总体采样率分别为100%和98.0%。 22G和25G组之间的采样率没有差异。细胞学和组织学的总体诊断准确率分别为94.8%和79.7%。 22G和25G组在细胞学上的准确率分别为94.3%和95.2%,而组织学上的准确率分别为80.0%和79.5%。在22G和25G组之间,细胞学和组织学的诊断准确性无明显差异。在153个组织学样本中,有PDAC的样本中有69.3%提供了足够的样本用于IHC分析。 IHC分析的成功率在22G组(67.1%)和25G(71.1%)组之间没有显着差异(P = .60)。22G和25G均提供了很高的诊断率,组织学准确率相当。使用22G或25G获得的EUS-FNAB标本同样可以用于IHC分析,并且可能适合诊断检查。需要进行进一步的研究,例如EUS-FNAB针头设计和新颖的细胞块制备,以获取足够的样品用于“精密医学”。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
站内服务
  • 写作辅导
  • 期刊发表
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号